deltatrials
Completed PHASE4 NCT01486615

Premedication With Melatonin and Alprazolam Combination Versus Alprazolam or Melatonin Alone

Premedication With Melatonin and Alprazolam Combination Versus Alprazolam or Melatonin Alone: a Randomized, Double Blind Placebo Controlled Study

Sponsor: B.P. Koirala Institute of Health Sciences

Conditions Anxiety
Interventions (alprax) alprazolam meloset (melatonin) placebo stresnil ( melatonin and alprazolam)
Updated 9 times since 2017 Last updated: Sep 6, 2012 Started: Oct 31, 2011 Primary completion: Jan 31, 2012 Completion: Jan 31, 2012

A PHASE4 clinical study on Anxiety, this trial is completed. The trial is conducted by B.P. Koirala Institute of Health Sciences and has accumulated 9 data snapshots since 2011. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

▶ Show 4 earlier versions

  1. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE4

  2. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

  3. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  4. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • B.P. Koirala Institute of Health Sciences
Data source: B.P. Koirala Institute of Health Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Dharān, Nepal